These non-healing wounds reduce patients’ quality of life through pain, infection, sepsis, and amputation.
Nitrix is a new, low-cost biomaterial that treats the root causes of chronic wounds – inflammation and poor vascularization – to promote healing.
Compared to other ECM devices, Nitrix is no more costly or complicated to produce, and it offers greater healing capabilities.